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Abstract
Background
Podoconiosis is a type of elephantiasis characterised by swelling of the lower legs. It is often
confused with other causes of tropical lymphedema and its global distribution is uncertain.
Here we synthesise the available information on the presence of podoconiosis to produce
evidence consensus maps of its global geographical distribution.
Methods and findings
We systematically searched available data on podoconiosis in SCOPUS and MEDLINE
from inception, updated to 10 May, 2019, and identified observational and population-based
studies reporting podoconiosis. To establish existence of podoconiosis, we used the num-
ber of cases reported in studies and prevalence data with geographical locations. We then
developed an index to assess evidence quality and reliability, assigning each country an evi-
dence consensus score. Using these summary scores, we then developed a contemporary
global map of national-level podoconiosis status.
There is evidence of podoconiosis in 17 countries (12 in Africa, three in Latin America,
and two in Asia) and consensus on presence in six countries (all in Africa). We have identi-
fied countries where surveillance is required to further define the presence or absence of
podoconiosis. We have highlighted areas where evidence is currently insufficient or conflict-
ing, and from which more evidence is needed.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007925 December 2, 2019 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Deribe K, Simpson H, Cano J, Pigott DM,
Weaver ND, Cromwell EA, et al. (2019) Mapping
the global distribution of podoconiosis: Applying an
evidence consensus approach. PLoS Negl Trop Dis
13(12): e0007925. https://doi.org/10.1371/journal.
pntd.0007925
Editor: Andrew S. Azman, Johns Hopkins
Bloomberg School of Public Health, UNITED
STATES
Received: July 24, 2019
Accepted: November 14, 2019
Published: December 2, 2019
Copyright: © 2019 Deribe et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: This work was primarily supported by a
grant from the Wellcome Trust [grant number
201900] to KD as part of his International
Intermediate Fellowships. SIH is funded by grants
from the Bill & Melinda Gates Foundation
(OPP1106023, OPP1093011, OPP1132415,
OPP1159934 and OPP1176062), Wellcome Trust
Conclusion
The global distribution of podoconiosis is not clearly known; the disease extent and limits
provided here inform the best contemporary map of the distribution of podoconiosis globally
from available data. These results help identify surveillance needs, direct future mapping
activities, and inform prevention plans and burden estimation of podoconiosis.
Author summary
The global distribution of podoconiosis is uncertain. With our current understanding of
its distribution still incomplete, many of the countries suspected to be endemic for podo-
coniosis are based on expert opinion and lack published evidence of confirmed cases. In
this study, we used multiple data sources and health metrics to identify countries with
presence and absence of podoconiosis with appropriate uncertainties. After assembling a
database of different evidence types we constructed a weighted score for each country
called ‘evidence consensus scores’. We used these scores to measure the certainty of the
presence and absence of podoconiosis. The maps produced help to identify evidence gaps
and uncertainties in the current global distribution of podoconiosis. Countries with evi-
dence of podoconiosis are mostly clustered in Africa, and a few in Asia and Latin America.
We have also identified countries with indeterminate status on the presence and absences
of podoconiosis. These countries are characterised by weak health systems and multiple
co-endemic diseases causing lower leg swelling, potentially leading to misdiagnosis of
podoconiosis. Given these challenges, we recommend intensified disease surveillance and
active case searching be implemented in areas where evidence is lacking.
Introduction
Podoconiosis is a neglected tropical disease (NTD) caused by long-term exposure to red clay
soil [1–3]. The disease results from a complex interaction between genetics and the environ-
ment occurring over many years and resulting in progressive bilateral swelling of the legs.
Podoconiosis has a significant impact on physical[4] and mental health[3], and imposes enor-
mous social [5, 6]and economic [7]burdens, limiting development in communities that are
often remote and disadvantaged. Despite these challenges, morbidity management is effective
[8, 9], strategies for preventive behavioural change have been developed[10], and criteria for
elimination have been defined[11].
In 2011, the World Health Organization (WHO) included podoconiosis on its list of other
NTDs[12]. Current interventions include prevention through consistent use of footwear from
an early age, regular foot hygiene and covering floors inside houses[13]. For those with the dis-
ease, the WHO-recommended lymphedema management consists of foot hygiene, foot care,
wound care, compression, exercises and elevation, treatment of acute attacks, and use of shoes
and socks to reduce further exposure to the irritant soil[8, 14, 15].
Despite increased global interest towards podoconiosis, its geographical distribution
remains largely uncertain. Historically, podoconiosis has been reported in 32 countries glob-
ally, but there is uncertainty about its current distribution due to the lack of comprehensive
surveillance[16]. Three countries (Cameroon, Ethiopia and Rwanda) have completed nation-
wide mapping of podoconiosis, which demonstrated substantial under-reporting of the disease
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[17–19]. Major reasons for underdiagnosis and/or under-reporting include profound stigma
towards patients which reduces their willingness to seek healthcare[20, 21], widespread mis-
conceptions about the cause of the disease, low awareness among health professionals and the
affected communities[6, 20–22], lack of resources for disease management within pro-
grammes, and frequency of misdiagnoses as other diseases which cause lower leg lymphedema
[23].
The misdiagnosis of podoconiosis is a particular challenge given the absence of point-of-
care diagnostic tests, combined with scarce knowledge of the disease among health workers in
many endemic countries. Misdiagnoses not only under-estimate the distribution and preva-
lence but may also over-estimate the burden of the misdiagnosed condition, with implications
for population-at-risk estimates and programme monitoring. Thus, the joint lymphatic filaria-
sis (LF) and podoconiosis mapping in Ethiopia conducted in 2013[24] reduced the estimated
population at risk of LF from 30 million to 5.6 million[25, 26]. This was substantially due to
misdiagnosis of podoconiosis lymphedema as LF cases, which had previously inflated the esti-
mated population at risk of LF within Ethiopia.
Mapping the global distribution of a condition is a prerequisite for effective strategy and
programme design. Estimating the global burden and population at risk of podoconiosis
requires clear understanding of its geographical limits and a list of affected countries[27]. We
aimed to synthesise the available data on podoconiosis occurrence and prevalence from both
the grey and peer-reviewed literature and score podoconiosis presence or absence for all 195
countries globally. We used an evidence consensus approach[28, 29] (a measure of how
strongly the combined evidence collection supports a podoconiosis-present or podoconiosis-
absent status), combining these data with estimates of country-level surveillance capacity to
delineate and quantify the strength of podoconiosis presence or absence globally for every
country.
Methods
Data sources
Data sources included systematic peer-reviewed literature, conference proceedings and
abstracts. We also used the information provided by Price’s monograph[2], which contains
extensive personal observations and communications with experts on non-filarial elephantiasis
in many parts of the world. Although it may not be very precise, this monograph[2] provides a
first attempt to delineate the potential geographical distribution of this disease. Peer-reviewed
literature was identified from searches of SCOPUS and MEDLINE databases, updated to 10th
May, 2019. Additional publications were identified from the reference lists of identified papers.
The detailed search strategy and complete systematic review has been reported previously[16].
We updated this systematic search, which was carried out in 2018, to include data from recent
publications[16, 30].
Search strategy and selection criteria
We searched for studies that reported the epidemiology of podoconiosis. In May 2019 we
searched SCOPUS and MEDLINE for all relevant studies that reported podoconiosis occur-
rence, prevalence, and incidence or case reports. We used the following search terms; “podo-
coniosis” OR “mossy foot” OR “non-filarial elephantiasis”. No time or language limits were
applied. We hand-searched the reference lists of all recovered documents for additional refer-
ences. Abstracts of all reports were read and full papers retrieved for those appearing to fulfil
selection criteria. Publications were eligible for inclusion in the evidence consensus if they
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reported the presence of podoconiosis regardless of the type of diagnostic approach used to
detect cases[30].
Quantifying evidence with a weighted scoring system
The methodology used for generating the geographical limits of podoconiosis was adapted
from previous studies on dengue[28] and the Leishmaniases[29]. Four primary evidence cate-
gories were used to determine a consensus on the presence or absence of podoconiosis: (1)
health reporting organisations; (2) peer-reviewed evidence of local podoconiosis occurrence;
(3) number of cases identified in surveys; (4) supplementary information assessing confound-
ing factors known to influence podoconiosis diagnosis (Fig 1).
In order to quantify evidence consensus, a weighted scoring system termed “evidence con-
sensus” was developed [28, 29]. This scheme attributed positive values to evidence of presence
and negative values to evidence of a lack of presence. The aim was to use an optimal subset of
evidence to consistently assess the strength of evidence for podoconiosis occurrence within a
given area.
Health reporting organisations
We used a map developed by WHO and a monograph written by Price[2] as a general over-
view for disease presence. A score of +3 was assigned if both sources agreed upon presence; 0
if they disagreed, and -3 if they agreed on absence.
Peer-reviewed evidence
From the literature database we assessed case reports based upon the contemporariness of the
data included as well as the diagnostics used to confirm podoconiosis cases. If the article con-
tained evidence from between 2000 and 2019 a +3 score was given, while if it was between
1990 and 1999 +2 was scored and for those before 1990 +1 was given. The contemporariness
of podoconiosis literature was based on the different eras of podoconiosis research. Pre-1990
studies are mostly marked based on rapid survey of people with lower leg swelling. Studies
conducted between 1990 and 1999 used some form of test, whereas those studies conducted
between 2000 and 2019 utilised some form of clinical algorithm including history, physical
examination and disease specific tests. This has been included in the supplementary material.
A variety of diagnostic methods have been described in the literature. We used the clinical
algorithm developed by Sime et al. as a gold standard diagnosis for podoconiosis, as this is the
only approach that satisfactorily eliminates other potential aetiologies. Articles using the Sime
et al[24] approach were assigned a score of +3, those using clinical diagnosis plus immuno-
chromatographic card test (ICT) to exclude filarial worm infection were assigned +2, and stud-
ies that simply reported cases without further diagnostic details were assigned +1.
Number of cases reported in studies included
For each country, we added the number of cases reported in all studies included. We checked
the sources of data to avoid double counting of cases. When two different studies reported
cases from the same source, the original study was used to identify the case numbers. Articles/
locations reporting more than 30 cases were given a score of +6, those with>15 and�30 were
scored +4, those with>5 and�15 were scored +2 and those with�5 cases were scored 0.
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Supplementary evidence
We attempted to account for the impact of possible misdiagnoses and underreporting by
assigning countries with no evidence of podoconiosis cases a score representing the evidence
for absence. This score integrated three components: diagnosis, surveillance, and sociodemo-
graphic development. Each ranged from 0 to 1 and was weighted equally.
The diagnosis score was intended to reflect the likelihood of misdiagnosis of podoconiosis
as other causes of lymphedema (LF, leprosy, and Tropical Ulcer (TU)), based on the distribu-
tions of these conditions and their prevalence relative to podoconiosis. We calculated the ratio
of podoconiosis to each other cause of lymphedema from selected lymphedema surveys [17–
19], and expressed this relationship as a proportion, reflecting a disease-specific misdiagnosis
score for each disease (details in S1 Appendix). We used data on the global distributions of LF,
leprosy and TU [29, 31–32] to define each country as endemic or non-endemic for each dis-
ease. For each country, the disease-specific misdiagnosis scores for its endemic diseases were
Fig 1. Evidence consensus framework used to assess the strength of evidence for the presence and absence of podoconiosis at the national level. A) Part A used for all
countries with reported cases from any study. B) For countries with no evidence of reported cases. Maximum possible score depends on which categories are included and
can vary from 15 (A) to 3 (B). HAQ = the Healthcare Access and Quality (HAQ) Index, SDI = Socio-Demographic Index.
https://doi.org/10.1371/journal.pntd.0007925.g001
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summed and rescaled to 0–1, representing a composite misdiagnosis score. This score was
then multiplied by a factor representing diagnostic capacity.
We measured diagnosis score and surveillance score based on the Healthcare Access and
Quality (HAQ) Index values, assuming lower levels of diagnostic capacity and surveillance in
countries with lower levels of personal health-care access and quality index. The HAQ Index
was developed by the Global Burden of Disease (GBD) to track national healthcare access[33].
The index is a score between 0 and 100. The index was estimated by a principal component
analysis of 32 causes considered amenable to health care. These causes are considered to pro-
vide a strong indication of what can and should be addressed by the recipient of effective
health care, thus performance on overall personal health-care access and quality. The diagnos-
tic capacity factor was calculated as the inverse of the HAQ Index[33] rescaled to 0–1. This fac-
tor was higher for countries with lower levels of personal health-care access and quality, giving
such countries less adjustment (down-weighting) of the misdiagnosis likelihood scores, repre-
senting a higher likelihood of misdiagnosis.
The surveillance score was equal to the diagnostic capacity factor (the inverse of the HAQ
Index rescaled 0–1). This score was intended to indicate low surveillance capacity, assuming
lower levels of surveillance in countries with lower levels of personal health-care access and
quality.
The sociodemographic index was intended to represent the propensity for podoconiosis
based on socio-demographic index. The Socio-Demographic Index (SDI)[33] is a composite
indicator developed by the GBD studies based on income, education, and fertility. SDI is pro-
vided in a 0–1 scale: zero represents the lowest income per capita, lowest educational attain-
ment, and highest total fertility rate, and one represents the highest income per capita, highest
educational attainment, and lowest total fertility rate[34, 35]. We used the inverse of the SDI,
rescaled to 0 (most developed) to 1 (least developed) as propensity for podoconiosis.
The absence score was calculated from the sum of the diagnosis score, surveillance score
and sociodemographic development score and was highest for countries co-endemic for lep-
rosy, LF and TU, with lower levels of the HAQ Index, and lower levels of socio-demographic
development[33, 35].
Evidence consensus scoring
By scoring the evidence categories mentioned above individually and then combining their
respective scores, we were able to calculate ‘‘evidence consensus,” a measure of how strongly
the combined evidence collection supports a podoconiosis-present or podoconiosis-absent sta-
tus. To derive an overall country evidence consensus score, the scores for all evidence catego-
ries were summed, and then divided by the maximum possible score and multiplied by 100.
Consensus was defined as either consensus (± 100), very strong (±75% to ±99%), strong
(±50% to ±74%), moderate (±25% to ±49%) presence or absence, indeterminate (0% to 24%),
or weak evidence of absence (-1% to -24%).
The base map of the global administrative areas was downloaded from the Natural Earth
(https://www.naturalearthdata.com/)[36]. All maps were produced using ArcGIS Desktop
v10.5 (Environmental Systems Research Institute Inc., Redlands CA, USA).
Results
Global distribution of podoconiosis based on evidence consensus
Fig 2 shows the geographical distribution of the occurrence data included in the present study.
The global distribution of podoconiosis as defined by the evidence consensus is shown in Fig
3. The mapped colour scale ranges from complete consensus on podoconiosis presence (navy),
Mapping the global distribution of podoconiosis
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to indeterminate podoconiosis status (light green), then through to complete consensus on
podoconiosis absence (yellow). The full list of the evidence used for each country and their
Fig 2. Podoconiosis occurrence data identified.
https://doi.org/10.1371/journal.pntd.0007925.g002
Fig 3. Evidence consensus for podoconiosis presence and absence worldwide. Absence of podoconiosis is yellow, areas with evidences consensus on podoconiosis status
is blue.
https://doi.org/10.1371/journal.pntd.0007925.g003
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scoring is available in Table S1. In our analysis, we identified 17 countries with evidence of
podoconiosis presence (i.e. positive values outside the indeterminate range). Additionally, we
have identified ten countries (Angola, Chad, Colombia, Democratic Republic of Congo, El Sal-
vador, French Guiana, Madagascar, Mozambique, Niger and Suriname) with indeterminate
status. The 17 podoconiosis-present and ten indeterminate status countries are indicated in
Table 1.
Distribution of podoconiosis in Africa
In Africa, 12 countries with podoconiosis presence were identified, with complete consensus
in six (Cameroon, Ethiopia, Kenya, Tanzania, Rwanda and Uganda). The evidence in these six
countries comes from local surveys and some nationwide mapping conducted in Ethiopia,
Rwanda and Cameroon [17–19]. In four countries (Burundi, Cape Verde, São Tome´ and Prı´n-
cipe and Sudan) there was strong evidence of presence of podoconiosis [2, 37–39]. The evi-
dence in these countries is mostly from surveys and published case reports. There was
moderate evidence of presence in Equatorial Guinea and Nigeria; the evidence in Equatorial
Guinea was based on a survey conducted in 1988[2, 40], whereas the evidence in Nigeria is
based on a case report in 2015[41]. In addition, both WHO and Price indicated the presence of
podoconiosis in Equatorial Guinea and Nigeria.
Table 1. Evidence consensus scores for the countries with evidences of presence and indeterminate categories.
SN Name Score Category
1 Cameroon 100 Consensus presence
2 Ethiopia 100 Consensus presence
3 Kenya 100 Consensus presence
4 Rwanda 100 Consensus presence
5 Uganda 100 Consensus presence
6 United Republic of Tanzania 100 Consensus presence
7 India 93 Very strong evidence for presence
8 Burundi 73 Strong evidence for presence
9 Sao Tome and Principe 67 Strong evidence for presence
10 Sudan 60 Strong evidence for presence
11 Cape Verde 60 Strong evidence for presence
12 Equatorial Guinea 47 Moderate evidence for presence
13 Nigeria 47 Moderate evidence for presence
14 Brazil 40 Moderate evidence for presence
15 Mexico 27 Moderate evidence for presence
16 Ecuador 27 Moderate evidence for presence
17 Indonesia 27 Moderate evidence for presence
18 Democratic Republic of Congo 7 Indeterminate
19 Niger 0 Indeterminate
20 Chad 0 Indeterminate
21 Madagascar 0 Indeterminate
22 Mozambique 0 Indeterminate
23 Angola 0 Indeterminate
24 El Salvador 0 Indeterminate
25 Colombia 0 Indeterminate
26 Suriname 0 Indeterminate
27 French Guiana 0 Indeterminate
https://doi.org/10.1371/journal.pntd.0007925.t001
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Indeterminate status was established for the Democratic Republic of Congo (DRC),
although podoconiosis was reported to be present in Price’s monograph[2]. However, this was
not supported by the WHO podoconiosis distribution map. The only available literature is
dated to 1939 and there is no contemporary evidence on the presence of podoconiosis in the
DRC[42]. In five countries (Angola, Chad, Madagascar, Mozambique and Niger) the presence
of podoconiosis was reported either by WHO or Price, but there was no literature to support
this, which resulted in an indeterminate status of the presence of podoconiosis in these
countries.
Most parts of southern and northern Africa, including Tunisia, Libya, Egypt and Western
Sahara were classified within the ‘strong evidence of absence’ category, where the disease has
either never been reported or has been eliminated, as it occurs in Algeria, Morocco and Tuni-
sia[2]. (Fig 4)
Distribution of podoconiosis in Asia
In Asia, two countries with podoconiosis presence were identified (India and Indonesia). In
India there is very strong evidence for presence, whereas in Indonesia there is moderate evi-
dence for presence. In India, we have identified two published articles and one conference pro-
ceeding reporting on podoconiosis [43–45]. Two of the studies were conducted in cities of
India (Imphal, Aizawal and Bikaner)[43, 44], whereas the third was conducted in Bhiwapur
area, Nagpur district, Maharashtra[45]. In Indonesia, podoconiosis was reported in the island
of Java[2]. The remaining Asian countries are characterized by absence. (Fig 5)
Distribution of podoconiosis in Latin America
In Latin America there are three countries (Brazil, Ecuador and Mexico) with moderate evi-
dence for presence of podoconiosis. In Brazil, while Price reported two cases in São Paulo[2],
another study in 1993 reported a case in Central Brazil[46]. Leon, in 1952 reported the pres-
ence of podoconiosis in Ecuador, in a subtropical region about 2000 m. above sea level[47]. In
addition, four countries (Colombia, El Salvador, French Guiana and Suriname) had indetermi-
nate status, indicating that more evidence is needed (Fig 6). In all four countries, Price[2] doc-
umented the presence of podoconiosis. Nonetheless, our literature search could not identify
literature on the presence of podoconiosis in these four countries.
In the rest of the world, most countries had very strong evidence or complete consensus for
podoconiosis absence. There are sixteen countries with weak evidence of absence including
Puerto Rico. Although neither WHO nor Price indicated the presence of podoconiosis, a pub-
lication dated 1922 mentioned the presence of podoconiosis in Puerto Rico[48]. The remain-
ing fifteen countries are characterized by low SDI, HAQ and the presence of the three
confounding diseases (LF, Leprosy and TU). Moreover, these countries neighbour countries
with evidence of podoconiosis, suggesting similar environmental niches.
Discussion
We have assembled available data on podoconiosis from multiple sources and synthesised
them through an evidence consensus framework, providing the first comprehensive list of
countries endemic for podoconiosis with varying levels of certainty. The maps generated pro-
vide information on the known limits of podoconiosis, and identify areas in which podoconio-
sis status is uncertain and requires additional information. These results have several
implications for future work on podoconiosis; from estimating its global burden and limits, to
targeting resources for control and case management, as well as prioritizing areas for surveil-
lance and research.
Mapping the global distribution of podoconiosis
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We identified evidence of podoconiosis in 17 countries and consensus on presence in six.
We have used supplementary information including the presence of confounding diseases
weighted by the HAQ Index and SDI, which enabled us to identify countries with weak sur-
veillance capacity and presence of confounding diseases which need further investigations.
Three countries with consensus on presence (Cameroon, Ethiopia and Rwanda) have
already mapped the distribution of podoconiosis [17–19]. The methods applied and lessons
learnt in mapping podoconiosis in these counties can be adapted to map the disease in the
remaining countries, with highest priority given to those with the strongest evidence for podo-
coniosis. Alongside mapping activities, the implementation of morbidity management inter-
ventions should also be prioritized in countries with evidence of podoconiosis presence.
Experience of mapping podoconiosis in Cameroon, Ethiopia and Rwanda indicates that the
Fig 4. Evidence consensus for podoconiosis presence and absence in Africa. Absence of podoconiosis is yellow, areas with evidences
consensus on podoconiosis status is blue.
https://doi.org/10.1371/journal.pntd.0007925.g004
Fig 5. Evidence consensus for podoconiosis presence and absence in Asia. Absence of podoconiosis is yellow, areas with evidences consensus on podoconiosis status is
blue.
https://doi.org/10.1371/journal.pntd.0007925.g005
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implementation of morbidity interventions in areas identified endemic will help in accelerat-
ing mapping and advocacy for elimination [24, 49]
India, Indonesia and Brazil are also among the countries with evidence of presence of podo-
coniosis. Given the large populations of these countries, their inclusion will have a substantial
impact on the estimated population at risk globally. Taking this into account, we aim to apply
an evidence consensus approach at the subnational-level in these countries, to identify whether
the disease is localized or widespread throughout them. A fine-scale approach will help us to
develop a robust and credible estimate of the global burden of podoconiosis and enable a tai-
lored approach to mapping and burden estimation.
We identified ten counties with strong or moderate evidence of podoconiosis. These coun-
tries could be categorised as a second priority group in terms of mapping and evidence genera-
tion. All have historical evidence of podoconiosis presence reported in the peer-reviewed
literature and Price’s monograph. In this category, Burundi is the only country in which an
extensive market-based survey was conducted by Price[50]. The survey indicated widespread
distribution of podoconiosis, although the data are from 1976. Most of the literature evidence
from these ten countries (except Nigeria) comes from the 1980’s, which implies that there is a
need to generate further evidence to qualify them. It is important that surveillance data should
be collected from these countries to further inform the evidence base before deciding on
nationwide mapping.
In ten countries (Angola, Chad, Colombia, Democratic Republic of Congo, El Salvador,
French Guiana, Madagascar, Mozambique, Niger and Suriname), podoconiosis status was
indeterminate. Neither WHO nor Price indicated the presence of podoconiosis in these coun-
tries[2], with no further peer-reviewed literature supporting this except in the Democratic
Republic of Congo. It is vital to further investigate the contemporary status of podoconiosis.
This can be achieved by strengthening surveillance systems to capture lymphedema cases. In
addition, we plan to work with the national Ministries of Health and partners in these coun-
tries to further investigate the presence of podoconiosis through questionnaires and review of
the existing health management information system[49].
The data and analysis presented herein are the first of their kind for podoconiosis. We have
compiled the largest dataset available globally for podoconiosis. In addition, we have used
other sources of data and evaluated potential for misclassification based on the surveillance
capacities of countries and the epidemiology of confounding diseases. Hence we employed the
most comprehensive approach to determine the list of countries endemic for podoconiosis.
We acknowledge several limitations to our approach, however, that are important to the inter-
pretation of the results and their future applications.
In this study, we focused on determining the presence or absence of podoconiosis at the
country level. From previous work, the distribution of podoconiosis within a country has
proven to be heterogeneous and we recognize the need for detailed (finer spatial resolution)
information for in-country planning and intervention[51, 52]. Ongoing work with endemic
countries such as India and Burundi is aimed at providing subnational administrative unit
prevalence levels that are relevant to decision making for podoconiosis.
In Latin America we identified only one case report from Brazil[46], making our evidence
consensus framework highly dependent on Price’s monograph[2], the country’s surveillance
capacity and the presence of confounding diseases. It will be critical to generate more data
Fig 6. Evidence consensus for podoconiosis presence and absence in Latin America. Absence of podoconiosis is yellow, areas with
evidences consensus on podoconiosis status is blue.
https://doi.org/10.1371/journal.pntd.0007925.g006
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from moderate evidence and indeterminate countries in the region. Our efforts to work with
regional professional associations are aimed at filling these data needs.
There is a marked difference in the availability of occurrence data globally. From all the
occurrence data, 79.2% were recorded from Cameroon and Ethiopia alone. This clearly indi-
cates that there is marked variation on research on podoconiosis. Although this may not affect
the current analysis, it may have implication on future analysis using the current database. Fol-
low up analysis should account for clustering of surveys from such few countries. In addition,
this implies the need for strengthening surveillance and research in other endemic countries.
The evidence consensus approach used here has several strengths such as the utilization of
multiple sources of data including published literature and health metrics which measure or
approximate surveillance and health system capacities. We used this method because podoco-
niosis is one of the most neglected tropical diseases and there is very limited understanding of
its presence and absence worldwide. Integrating health system metrics into the scoring system
enabled us to give an indication of the uncertainty associated with the lack of data in many
countries. This approach, however, does not capture the spatial heterogeneity in the potential
distribution of the disease within countries. Thus, in countries where there is high consensus
of podoconiosis presence, the disease may in fact be limited to certain areas. We are addressing
the problem of spatial heterogeneity in a subsequent research study, which will build upon the
outcomes of present study. Finally the evidence consensus approach doesn’t provide any evi-
dence of prevalence or burden, but could help to guide further studies to help elucidate these.
The evidence consensus work presented here will be important for future work. The evidence
consensus maps developed here can be integrated into a geospatial modelling framework
intended to ascertain the global burden of podoconiosis. Prevalence models can be informed
by the evidence consensus maps presented here.
In conclusion, we provide empirical evidence of the occurrence of podoconiosis and a list
of countries endemic for the disease. Countries with the highest evidence consensus are the
countries which should be targeted for further research, surveillance and initiation of preven-
tion and control programmes. Mapping should be done in these countries to determine the
in-country distribution and limits of podoconiosis which are critical for programme-level
decision making[27]. Some countries with strong evidence were not historically identified as
endemic for podoconiosis, which needs further study. Our compiled data form an important
database for developing podoconiosis risk models and estimation of the global population at
risk and ultimately burden for this avoidable NTD.
Supporting information
S1 Appendix. Evidence consensus categories results and literature sources.
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